Stay updated with breaking news from Zuma 12 trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients with high-risk large B-cell lymphoma experienced durable responses when treated with first-line axicabtagene ciloleucel, according to results from the phase 2 ZUMA-12 trial. ....